Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
License Agreement with Romark Laboratories and Development of Nitazoxanide in Japan
Chugai Pharmaceutical Co., 03/18/09
Chugai Pharmaceutical Co., Ltd. announced that Chugai has concluded a license agreement with Romark Laboratories obtaining exclusive rights in Japan to develop, manufacture and distribute nitazoxanide, a therapeutic agent that Romark has been developing overseas for chronic hepatitis C, and that Chugai has decided to develop nitazoxanide in Japan.
Today in Licensure/Accreditation...keeping you current
Receive free subspecialty "5-minute updates" via email
EDI Accrediting Firm Updates Criteria
HealthDataManagement, 12/09/09
Consumer Demand for H1N1 Information Highlights Importance of Accreditation for Health Call Centers
URAC News Releases, 12/07/09
The Joint Commission’s Hospital Accreditation Recognized by CMS
Joint Commission news, 12/03/09
Article Search
Sponsor


See Latest Articles


